On January 26, 2022, the HAS published standards for medical telemonitoring of four chronic pathologies (chronic respiratory failure, chronic heart failure, chronic renal failure, and diabetes). These standards must be met by technologies in order to be reimbursed by the new reimbursement framework for telemonitoring, which is expected to enter into force in July 2022. The 5th standard for patients with implantable cardiac devices (defibrillators and implantable pacemakers) will be published in early March 2022.
Following the experiments under the ETAPES program for telemonitoring of chronic pathologies, a reimbursement framework for medical telemonitoring is planned to enter into force on July 1, 2022. These standards define technical and organizational requirements for medical telemonitoring adopted by the National Committee for the evaluation of medical devices and health technologies (CNEDiMTS). Each standard defines the prescription conditions for remote monitoring, minimum technical specifications required for digital medical devices, distribution conditions, terms of use, professionals involved and their qualifications, organizational aspects, minimum conditions for ensuring the quality of care, monitoring the use of medical telemonitoring.
The full details in French can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).